Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteenvisiatherapeuti...
Twitter@EnvisiaTx
CategoryBioTech
Phone(919) 973-1440
Emailinfo@envisiathera...
Employees
Founded2013

Offices

Morrisville, USA
419 Davis Drive
Suite 100
Morrisville, NC, 27560
USA

People

CEO
CFO
CMO
Chief Scientific Officer

Funding

TOTAL $25M
FUNDING TOTAL $25M
Series A, 11/2013
$25M

Tags

Envisia Therapeutics

As many as 285 million people suffer from disease-related visual impairments and blindness1, but an estimated 80 percent of these visual impairments are actually preventable2. Unfortunately, the safety and effectiveness of many medical therapies for ocular disorders are limited due to poor drug uptake, non-specificity to target tissues, systemic side effects, or poor adherence to therapy. With a rapidly aging population, the unmet medical needs in ocular disease are becoming even more pronounced. As a result, patients and physicians are seeking improved ocular therapeutics that can significantly enhance patient outcomes and convenience.

Recent Milestones

Videos

Screenshots

Envisia Therapeutics screenshot
Above: Homepage
Uploaded: 11/12/13

Sources

  1. Envisia Therapeutics Debuts with $25 Million Series A Financing (ca.finance.yahoo.com) [edit]
Edit This Page
Last Edited 11/12/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy